Skip to content

Ceftobiprole OATP1B interaction study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518592-60-00
Acronym
BPR-CP-101
Enrollment
12
Registered
2024-12-24
Start date
2025-01-17
Completion date
2025-02-25
Last updated
2024-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired bacterial pneumonia

Interventions

None listed

Sponsors

Basilea Pharmaceutica International AG Allschwil
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026